A Drosophila model of Parkinson's disease

Nature

Volumn 404, Issue 6776, 2000, Pages 394-398

  Feany, Mel B ^a   Bender, Welcome W ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

ARTICLE; DISEASE ASSOCIATION; DROSOPHILA; IMMUNOCYTOCHEMISTRY; MOTOR DYSFUNCTION; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALPHA-SYNUCLEIN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; DOPAMINE; DROSOPHILA; HUMANS; INCLUSION BODIES; LEWY BODIES; LOCOMOTION; MUTATION; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURONS; PARKINSON DISEASE; RETINAL DEGENERATION; SEROTONIN; SYNUCLEINS; TYROSINE 3-MONOOXYGENASE;

INSECTA;

EID: 0034704752     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35006074     Document Type: Article

References (30)

1. Polymeropoulos, M. H. et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047 (1997).
2. Krüger, R. et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nature Genet. 18, 106-108 (1998).
3. Spillantini, M. G., Schmidt, M. L., Lee, V. M. -Y. & Trojanowski, J. Q. α-Synuclein in Lewy bodies. Nature 388, 839-840 (1997).
4. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. α-Synuclein filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469-6473 (1998).
5. Baba, M. et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879-884 (1998).
6. Brand, A. H. & Perrimon, N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415 (1993).
7. Warrick, J. M. et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93, 939-949 (1998).
8. Budnik, V., Martin-Morris, L. & White, K. Perturbed pattern of catecholamine-containing neurons in mutant Drosophila deficient in the enzyme dopa decarboxylase. J. Neurosci. 6, 3682-3691 (1986).
9. Budnik, V. & White, L. Catecholamine-containing neurons in Drosophila melanogaster. Distribution and development. J. Comp. Neurol. 268, 400-413 (1988).
10. Lundell, M. J. & Hirsh, J. Temporal and spatial development of serotonin and dopamine neurons in the Drosophila CNS. Dev. Biol. 165, 385-396 (1994).
11. Gibbs, W. R. G. & Lees, A. J. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 54, 388-396 (1991).
12. Coombe, P. E. & Heisenberg, M. The structural brain mutant Vacuolar medulla of Drosophila melanogaster with specific behavioral defects and cell degeneration in the adult. J. Neurogenet. 3, 135-158 (1986).
13. Buchanan, R. L. & Benzer, S. Defective glia in the Drosophila brain degeneration mutant drop-dead. Neuron 10, 839-850 (1993).
14. Jellinger, K. A. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol. Chem. Neuropathol. 14, 153-197 (1991).
15. Vallés, A. M. & White, K. Serotonin-containing neurons in Drosophila melanogaster: Development and distribution. J. Comp. Neurol. 268, 414-428 (1988).
16. Kuzuhara, S., Mori, H., Izumiyama, N., Yoshimura, M. & Ihara, Y. Lewy bodies are ubiquitinated: a light and electron microscopic immunocytochemical study. Acta Neuropathol. 75, 345-353 (1988).
17. Dickson, D. W. et al. Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol. 78, 572-584 (1987).
18. Pollanen, M. S., Dickson, D. W. & Bergeron, C. Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52, 183-191 (1993).
19. Ganetzky, B. & Flanagan, J. R. On the relationship between senescence and age-related changes in two wild-type strains of Drosophila melanogaster. Exp. Gerontol. 13, 189-196 (1978).
20. Le Bourg, E. & Lints, F. A. Hypergravity and aging in Drosophila melanogaster. 4. Climbing activity. Gerontology 38, 59-64 (1992).
21. Franceschini, N. in Information Processing in the Visual System of Drosophila (ed. Wehner, R.) 75-82 (Springer, Berlin, 1972).
22. Conway, K. A., Harper, J. D. & Lansbury, P. T. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nature Med. 4, 1318-1320 (1998).
23. Narhi, L. et al. Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J. Biol. Chem. 274, 9843-9846 (1999).
24. El-Agnaf, O. M. A. et al. Aggregates from mutant and wild-type α-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of β-sheet and amyloid-like filaments. FEBS Lett. 440, 71-75 (1998).
25. Ostreova, N. et al. α-synuclein shares physical and functional homology with 14-3-3 proteins. J. Neurosci. 19, 5782-5791 (1999).
26. Hong, L. et al. The cDNA cloning and ontogeny of mouse α-synuclein. NeuroReport 9, 1239-1243 (1998).
27. Masliah, E. et al. Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269 (2000).
28. Li, H., Chaney, S., Forte, M. & Hirsh, J. Ectopic G-protein expression in dopamine and serotonin neurons blocks cocaine sensitization in Drosophila melanogaster. Curr. Biol. (in the press).
29. Robinow, S. & White, L. The locus elav of Drosophila melanogaster is expressed in all neurons at all developmental stages. Dev. Biol. 126, 294-303 (1988).
30. Ellis M., O'Neill, E. & Rubin, G. Expression of Drosophila glass protein and evidence for negative regulation of its activity in non-neuronal cells by another DNA-binding protein. Development 119, 855-865 (1993).